NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort

CompletedN/A

Sponsor: Imperial College London

Conditions: COVID-19, SARS-CoV 2, ARDS, Human, Immune System Disorder

Interventions: Blood tests sputum, nasal lavage and brushing

Countries: United Kingdom

DESIGN Longitudinal prospective observational multicentre study. Primary objective: Understand the immune mechanisms driving COVID-19 disease in patients with a history of lung disease

Eligibility overview

Sex: ALL

Age: 16 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. All patients ≥16 years old with confirmation of COVID-19
2. All patients ≥ 16 years old with chronic lung disease (CF, non-CF bronchiectasis, asthma, COPD or Idiopathic Pulmonary Fibrosis) or with no evidence of prior chronic lung disease
3. Healthy volunteers

Exclusion Criteria:

None

Locations (1)

London, London, United Kingdom